Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs. 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE‑2 Randomized Clinical Trial - Hortobagyi, G N; Van Poznak, C; Harker, W G (JAMA Oncol, 2017)
et al.